Laser remote sensing calibration of ocean color satellite data

Autor: N. V. Kolodnikova, L. Fiorani, F. Colao, R. Fantoni, R. Barbini, A. Palucci

Publikováno v: Annals of Geophysics, Vol 49, Iss 1 (2006)

world ocean: in fact, those processes dramatically affect the climatic equilibrium of our planet. For this reason, many advanced active and passive remote sensors have been used to study phytoplankton dynamics, since such phenomena are thought to be

Externí odkaz: https://doaj.org/article/b32c2890811e481e8187d3be5aa5f535

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques

Autor: Milos D. Ikonomovic, Enrico R. Fantoni, Gill Farrar, Stephen Salloway

Publikováno v: Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-4 (2018)

Abstract Background The performance of [18F]flutemetamol amyloid PET against histopathological standards of truth was the subject of our recent article in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (2017;9:25–34). Main bod

Externí odkaz: https://doaj.org/article/a9494674e9af4bc69a5ec0403de10e82

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Identification of materials in oil paintings through studies of correlations and ratios between the element line intensities during LIBS stratigraphy

Autor: V. Lazic, M. Romani, L. Pronti, M. Angelucci, M. Cestelli-Guidi, M. Mangano, R. Fantoni

Publikováno v: Spectrochimica Acta Part B: Atomic Spectroscopy. 201:106601

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::61fa15b339f70b709e1a4794f53a2df8
https://doi.org/10.1016/j.sab.2022.106601

What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals?

Autor: Christophe Bintener, Michael Sharwood Smith, Michele Potashman, Amanda Ly, Alex McKeown, Christoph Jindra, Anders Gustavsson, Emilse Roncancio-Diaz, Cathie Sudlow, Olin Janssen, Anna Ponjoan, Claire Tochel, Stephanie J.B. Vos, Isabella Friis Jørgensen, Buket Öztürk, Catherine Reed, Josep Garre-Olmo, Mia Nelson, Christin Bexelius, Helen Baldwin, Enrico R. Fantoni

Publikováno v: Tochel, C, Smith, M, Baldwin, H, Gustavsson, A, Ly, A, Bexelius, C, Nelson, M, Bintener, C, Fantoni, E, Garre-Olmo, J, Janssen, O, Jindra, C, Jørgensen, I F, McKeown, A, Öztürk, B, Ponjoan, A, Potashman, M H, Reed, C, Roncancio-Diaz, E, Vos, S & Sudlow, C 2019, ' What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review ', Alzheimer's & Dementia, vol. 11, pp. 231-247 . https://doi.org/10.1016/j.dadm.2018.12.003
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Alzheimers & Dementia: Diagnosis, Assessment & Disease Monitoring
Tochel, C, Smith, M, Baldwin, H, Gustavsson, A, Ly, A, Bexelius, C, Nelson, M, Bintener, C, Fantoni, E, Garre-Olmo, J, Janssen, O, Jindra, C, Jorgensen, I, McKeown, A, Ozturk, B, Ponjoan, A, Potashman, M, Reed, C, Roncancio-Diaz, E, Vos, S & Sudlow, C 2019, ' What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review ', Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring . https://doi.org/10.1016/j.dadm.2018.12.003
Tochel, C, Smith, M, Baldwin, H, Gustavsson, A, Ly, A, Bexelius, C, Nelson, M, Bintener, C, Fantoni, E, Garre-Olmo, J, Janssen, O, Jindra, C, Jørgensen, I F, McKeown, A, Öztürk, B, Ponjoan, A, Potashman, M H, Reed, C, Roncancio-Diaz, E, Vos, S, Sudlow, C & ROADMAP consortium 2019, ' What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review ', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, vol. 11, pp. 231-247 . https://doi.org/10.1016/j.dadm.2018.12.003
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 11(1), 231-247. Elsevier BV
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 231-247 (2019)

Introduction: Clinical trials involving patients with Alzheimer’s disease (AD) continue to try to identify disease-modifying treatments. Although trials are designed to meet regulatory and registration requirements, many do not measure outcomes of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0b9fc902e29a50872ed92ca7654b159
https://cris.maastrichtuniversity.nl/en/publications/0f468330-2ae5-4972-b0a4-e3b057ce4213